Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jad Chahoud"'
Autor:
Jad Chahoud, Rohit Jain, C. Araujo, Jasreman Dhillon, A. Vosoughi, R. Li, Y. Kim, M. Chatwal, Guru Sonpavde, J. Zhang
Publikováno v:
Annals of Oncology. 32:S724
Autor:
Young-Chul Kim, Jad Chahoud, Jacob J. Adashek, S. Shah, P.E. Spiess, Nadya Mason, B.J. Manley
Publikováno v:
Annals of Oncology. 32:S692
Autor:
Amishi Yogesh Shah, A. Zurita Saavedra, Eric Jonasch, Jad Chahoud, Andrew James Wiele, Nizar M. Tannir, Lianchun Xiao, Jeremy A. Ross, Zita Dubauskas Lim, Matthew T. Campbell
Publikováno v:
Annals of Oncology. 30:v390
Background ICI and VEGFR-targeted therapies are the primary treatments for mRCC. Len plus Eve is currently approved based on improved progression-free survival (PFS) in pts with progressive disease after one prior VEGFR-targeted therapy. However, its